Back
16 July 2024
The ITA reports that a sample collected during a targeted pre-competition test prior to the Olympic Games Paris 2024 on 27 June 2024 from Dorota Borowska has returned an Adverse Analytical Finding (AAF)¹ for the prohibited substance “Clostebol metabolite”.
Clostebol metabolite is prohibited under the 2024 WADA Prohibited list as an anabolic androgenic steroid (S1.1). It is prohibited at all times (in-competition and out-of-competition). Further, considering that it is a non-specified substance; a provisional suspension is mandatory under Art 7.4.1 of the ICF Anti-Doping Rules.
During the period of provisional suspension the athlete cannot compete in any competition either at the national or international level or any other activity until the resolution of the matter.
The athlete has been informed of the case of her provisional suspension. She has to right to request the analysis of the B-sample and a provisional hearing or an expedited final hearing.
Pursuant to the ICF’s delegation of its anti-doping program for to the ITA, the results management and prosecution of the case is being handled entirely by the ITA.
No further comments will be made on this case.
